Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 823 results for "ldl"

Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol
Morningstar.com

Sanofi : and Regeneron Announce New Results from Six Phase 3 T...

By a News Reporter-Staff News Editor at Biotech Week -- Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced new detailed positive results from six Phase 3 ODYSSEY trials that showed alirocumab significantly reduced low-density ... 4 Traders, 5 hours ago
[x]  

77 images for ldl

Redland People, 1 day ago
Kitchens Review, 5 days ago
Pharma Letter, 1 week ago
The KBzine, 1 week ago
Exmouth People, 4 hours ago
Rochester People, 6 hours ago
Exmouth People, 1 day ago
Arundel People, 1 day ago
Whitstable People, 2 days ago
MDLinx, 2 days ago

Evolocumab Lowers LDL in Genetic High Cholesterol Disorder

JAMA. 2014;312(20):2083. doi:10.1001/jama.2014.15519. Text Size: A A A Extract Evolocumab (AMG145), inhibitor of an enzyme (PCSK9) that facilitates degradation of low-density lipoprotein (LDL) receptors, led to 60% greater reduction in LDL ...
 Journal of the American Medical Association1 day ago

Earnings Look Back: Lydall Is Down 9.7% Since Reporting Quarterly Results 2 Weeks Ago (LDL)

(Comtex SmarTrend(R)) When Lydall (NYSE:LDL) reported earnings two weeks ago on November 5th, 2014, analysts, on average, expected the company to report earnings of $0.42 on sales of $135.0 million. The company actually reported EPS of $0.43 on ...
 Individual.com2 days ago Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Lydall Is Down 9.7% (LDL)  Individual.com4 days ago Lydall Earnings Review: 12 Days after Announcement Shares Down 5.2% (LDL)  Individual.com1 week ago

Will The IMPROVE-IT Results Impact The Thinking Of The FDA And Payers On LDL-Cholesterol Lowering Drugs?

There is no doubt that statins, drugs like Lipitor and Zocor that lower LDL-cholesterol, reduce the occurrence of heart attacks and strokes in those with cardiovascular disease (CVD). For a long time people have debated whether statins are unique or ...
 Forbes.com1 week ago Is it Time to Ditch the Friedewald Equation?  Clincial Laboratory News1 week ago Cholesterol drugs work—even after you stop taking them  American Council On Science & Health1 day ago

Do The IMPROVE-IT Results Offer Promise For Another Merck Heart Drug - Anacetrapib?

Despite the fact that anacetrapib lowers LDL at least as well as Vytorin did in IMPROVE-IT, the FDA would never approve anacetrapib based solely on LDL lowering. This is a new experimental agent and the results of REVEAL are needed before the FDA ...
 Austin American Statesman5 days ago Merck's acute coronary syndrome study meets primary and secondary endpoints  Individual.com1 day ago IMPROVE-IT Gives Another Merck Drug Promise  Forbes.com5 days ago Physician Views: What impact will the IMPROVE-IT study have on the treatment landscape?  FirstWord Pharma1 week ago
[x]  
IFI Online

New Beverage Targets LDL Cholesterol

Naturex says it will showcase innovative natural food and beverage concepts that promote healthy aging at the forthcoming Health Ingredients Europe 2014, including one that targets LDL cholesterol. The EU's regulatory environment has caused many ...
 Beverage World1 week ago - At HIE 14, Naturex to showcase food and beverage concepts for seniors  FnBnews.com1 day ago Naturex develops new wellbeing solutions for seniors  Food Drink Business Europe6 days ago Naturex announces plans for Hi Europe  IFI Online1 week ago

Regeneron Drug Lowers LDL for Patients Who Cant Take Statins

Reuters | Just a day after Merck reported strong results from its IMPROVE-IT Vytorin trial, Regeneron presented its own clinical trial saying its drug helped 10 times as many patients lower
 Clinical Informatics News1 week ago REGENERON, SANOFI DRUG FAR MORE EFFECTIVE AT LOWERING LDL CHOLESTEROL THAN MERCK'S ZETIA IN STATIN INTOLERANT PATIENTS - STUDY  CNBC1 week ago AHA.14: PCSK9 inhibitor safe, effective in statin-intolerant patients  Cardiovascular Business1 week ago ODYSSEY ALTERNATIVE: Alirocumab superior to ezetimibe for LDL lowering in statin-intolerant patients  Orthopedics Today1 week ago
[x]  

Amgen Claims It All

Summary There's plenty of excitement about PCSK9, the latest LDL-lowering pathway to make it deep into the clinic. There are at least five antibodies and one RNAi in development, in a very tight race to the FDA and to the market. I don't think ...
 Seeking Alpha5 days ago

Shares of Donaldson Rank the Lowest in Terms of EPS Growth in the Industrial Machinery Industry (DCI, BMI, SPW, IEX, LDL)

(Comtex SmarTrend(R)) Below are the three companies in the Industrial Machinery industry with the lowest year-over-year expected earnings per share (EPS) growth rates. The long-term growth rate is the expected annual increase in operating EPS over ...
 Individual.com5 days ago

Lowest PEG Ratio in the Industrial Machinery Industry Detected in Shares of Chart Industries (GTLS, SPW, LDL, KAI, MIDD)

(Comtex SmarTrend(R)) Below are the three companies in the Industrial Machinery industry with the lowest price to earnings to growth (PEG) ratios. PEG is valuable in assessing the tradeoff between the price of a stock and expected growth. ...
 Individual.com6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less